Dr. Chitnis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
60 Fenwood Road, 1B
Neurology
Boston, MA 02115Phone+1 617-525-6550Fax+1 617-525-6554- Is this information wrong?
Education & Training
- Drexel University College of Medicine/Hahnemann University HospitalResidency, Neurology, 1995 - 1998
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1994 - 1995
- University of Toronto Faculty of MedicineClass of 1994
Certifications & Licensure
- NH State Medical License 2023 - 2025
- ME State Medical License 2021 - 2024
- RI State Medical License 2021 - 2024
- MA State Medical License 1999 - 2024
- PA State Medical License 1995 - 1998
- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- Environmental and Genetic Risk Factors for Pediatric Multiple Sclerosis Start of enrollment: 2011 Oct 01
- Comparison of Rebif Compared to Tecifdera on Six-month Outcomes in Patients With Relapsing-remitting MS Start of enrollment: 2015 May 01
Publications & Presentations
PubMed
- Teriflunomide in pediatric patients with relapsing multiple sclerosis: Open-label extension of TERIKIDS.Ludwig Kappos, Douglas L Arnold, Kivilcim Gücüyener, Kumaran Deiva, Stephane Saubadu, Wenruo Hu, Myriam Benamor, Annaig Le-Halpere, Philippe Truffinet, Marc Tardieu, T...> ;Multiple Sclerosis. 2024 Apr 15
- 1 citationsPredictors of relapsing disease course following index event in myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD).Bilodeau, P., Rebecca Salky, Gauruv Bose, Itay Lotan, Gabriela Romanow, Monique R Anderson, Marcelo Matiello, Tanuja Chitnis, Michael Levy, Philippe A Bilodeau, Negar ...> ;Journal of the Neurological Sciences. 2024 Mar 15
- Gene-environment interactions: Epstein-Barr virus infection and risk of pediatric-onset multiple sclerosis.Ziaei, A., Solomon, O., Casper, T., Waltz, M., Weinstock-Guttman, B., Aaen, G., Wheeler, Y., Graves, J., Benson, L., Gorman, M., Rensel, M., Mar, S., Lotze, T., Greenb...> ;Multiple Sclerosis. 2024 Mar 1
- Join now to see all
Journal Articles
- Autologous Hematopoietic Stem Cell Transplant in Multiple SclerosisTanuja Chitnis, Nancy L Sicotte, JAMA Neurology
- Trial of Fingolimod Versus Interferon Beta-1a in Pediatric Multiple SclerosisJerry S Wolinsky, Lauren Krupp, Emmanuelle Waubant, Tanuja Chitnis, Brenda Banwell, Kevin Rostasy, The New England Journal of Medicine
Press Mentions
- Alzheimer’s Vaccine: Nasal Spray Trial Shows Promise, Researchers SayDecember 2nd, 2022
- Tiziana Starts Enrolment in Secondary Progressive MS Expanded Access ProgrammeOctober 27th, 2022
- 16 People Are About to Help Test This Nasal Vaccine for Alzheimer’sMay 17th, 2022
- Join now to see all
Committees
- Board Member, ACTRIMS - Americas Committee for Treatment and Research in MS 2020 - Present
- Board Member, National Multiple Sclerosis Clinical Advisory Committee 2019 - Present
- Chair, International Pediatric Multiple Sclerosis Study Group (IPMSSG) 2010 - 2018
Professional Memberships
- Member
Other Languages
- French, Marathi
Hospital Affiliations
- Brigham and Women's HospitalBoston, Massachusetts
- Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: